JPRN-C000000380已完成4 期
The renoprotective effects of ARB in patients with IgA nephropathy : multicenter,radomized trial - ARB and IgA nephropathy
ARB therapeutic society of IgA nephropathy0 个研究点目标入组 400 人开始时间: 2006年3月31日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)patients with nephrotic syndorome. 2)patients who administered steroid or discontinuted within 6 months prior to enrolment in the study. 3)patients with serious liver dysfunction. 4)pregnant women or women of child bearing potential and nursing women. 5)patients with hypersensitivity to angiotensin II receptor blocker and angiotensin convertig enzyme inhibitor. 6)Other patients who are judged to be inappropriate for the study by the investigator or subinvestigator.
研究者
相似试验
已完成
不适用
Cardioprotective effect of ARB in old patients with hypertension and coronary artery disease - a multicenter trial -.Elderly patients with hypertension and coronary artery diseaseJPRN-UMIN000007273Association of APPOINT-study100
尚未招募
4 期
Effect of ARB and diuretics combination therapy on home blood pressure by using telemedicine systemHypertensionJPRN-UMIN000003846Department of General Internal Medicine, Saitama Medical School50
已完成
不适用
A comparative study of renoprotective effect of tolvaptan as an alternative treatment for increasing loop diuretics in patients with chronic kidney disease complicated with chronic heart failurechronic heart failure, chronic kidney diseaseJPRN-UMIN000036119Kawashima hospital40
进行中（未招募）
1 期
This study will assess the effects of dapagliflozin (a drug that is used in patients with Type 2 Diabetes) on lowering the level of urine protein in patients with non-diabetic kidney disease.Chronic kidney diseaseEUCTR2017-001090-16-NLniversity Medical Center Groningen53
已完成
不适用
An exploratory clinical study of the renoprotective effect of empagliflozin and the verification of companion diagnostics in type 2 diabetes patientsType 2 diabetes mellitusJPRN-UMIN000023902Department of Applied Molecular Medicine, Niigata University Graduate School of Medical and Dental Sciences51